Rock2tm1c(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Rock2tm1c(KOMP)Wtsi |
Name: |
Rho-associated coiled-coil containing protein kinase 2; targeted mutation 1c, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:6342426 |
Gene: |
Rock2 Location: Chr12:16944896-17037824 bp, + strand Genetic Position: Chr12, 8.04 cM, cytoband A3
|
Alliance: |
Rock2tm1c(KOMP)Wtsi page
|
IMPC: |
Rock2 gene page |
|
Mutant Cell Line: |
EPD0492_1_C01 |
Germline Transmission: |
Earliest citation of germline transmission:
J:240629
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Conditional ready) |
Mutation: |
|
Insertion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 16978465 of Chromosome 12 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon(s) at position 16979257. The critical exon(s) is/are thus flanked by loxP sites. A "conditional ready" (floxed) allele was created by flp recombinase expression in mice carrying this allele to remove the lacZ sequence and neo selection cassette, leaving loxP sites flanking the critical exon(s). Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:240629)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Rock2 Mutation: |
60 strains or lines available
|
|
Original: |
J:240629 Rath N, et al., ROCK signaling promotes collagen remodeling to facilitate invasive pancreatic ductal adenocarcinoma tumor cell growth. EMBO Mol Med. 2017 Feb;9(2):198-218 |
All: |
3 reference(s) |
|